Do you want to read an article? Please log in or register.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
Further Publications
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)